191104-26-4

Basic information

• Product Name: 3-VINYL-5-BROMO-PYRIDINE
• Synonyms: 3-VINYL-5-BROMO-PYRIDINE;3-BroMo-5-ethenylpyridine
• CAS NO: 191104-26-4
• Molecular Formula: C7H6BrN
• Molecular Weight: 184.03
• Mol File: 191104-26-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 217.136 ºC at 760 mmHg
• Flash Point: 85.121 ºC
• Appearance: /
• Density: 1.475 g/cm³
• Vapor Pressure: 0.198mmHg at 25°C
• Refractive Index: 1.605
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.51±0.20(Predicted)
• CAS DataBase Reference: 3-VINYL-5-BROMO-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-VINYL-5-BROMO-PYRIDINE(191104-26-4)
• EPA Substance Registry System: 3-VINYL-5-BROMO-PYRIDINE(191104-26-4)

Safety Data

• Hazardous Substances Data: 191104-26-4(Hazardous Substances Data)

Usage

General Description

3-Vinyl-5-bromo-pyridine is a chemical compound with the molecular formula C7H6BrN. It is a vinyl-substituted derivative of pyridine, featuring a vinyl group and a bromine atom attached to the 5-position of the pyridine ring. 3-VINYL-5-BROMO-PYRIDINE is commonly used as a versatile building block in organic synthesis, particularly in the preparation of various pharmaceuticals, agrochemicals, and fine chemicals. Its reactivity and unique structure make it a valuable intermediate in the synthesis of diverse organic compounds. Additionally, 3-vinyl-5-bromo-pyridine is known for its potential applications in the field of material science, particularly in the production of functional polymers and advanced materials.

InChI:InChI=1/C7H6BrN/c1-2-6-3-7(8)5-9-4-6/h2-5H,1H2

Upstream product

• 625-92-3 3,5-dibromopyridine 
• 28733-43-9 5-bromonicotinamide 
• 113118-81-3 5-bromopyridine-3-carbaldehyde 
• 1779-49-3 Methyltriphenylphosphonium bromide 

Relevant articles and documents

5-PYRIDIN-3-YL-1,3-DIHYDRO-INDOL-2-ON DERIVATIVES AND THEIR USE AS MODULATORS OF ALDOSTERONE SYNTHASE AND/OR CYP11B1

The present invention provides a compound a formula (I); or a pharmaceutically acceptable salt thereof, wherein: X is CH2, O, S or-NR1; each R1 are independently C1-7alkyl or C3-8cycloalkyl; each of R

Inhibitors of protein isoprenyl transferases

Compounds having the formula or a pharmaceutically acceptable salt thereof wherein R1 is (a) hydrogen, (b) loweralkyl, (c) alkenyl, (d) alkoxy, (e) thioalkoxy, (f) halo, (g) haloalkyl, (h) aryl-L2—, and (i) heterocyclic-L2—; R2 is selected from (a) (b) —C(O)NH—CH(R14)—C(O)OR15, (c) (d) —C(O)NH—CH(R14)—C(O)NHSO2R16 (e) —C(O)NH—CH(R14)-tetrazolyl, (f) —C(O)NH-heterocyclic, and (g) —C(O)NH—CH(R14)—C(O)NR17R18; R3 is heterocyclic, aryl, substituted or unsubstituted cycloalkyl; R4 is hydrogen, lower alkyl, haloalkyl, halogen, aryl, arylakyl, heterocyclic, or (heterocyclic)alkyl; L1 is absent or is selected from (a) —L4—N(R5)—L5—, (b) —L4—O—L5—, (c) —L4—S(O)n—L5— (d) —L4-L6—C(W)—N(R5)—L5—, (e) —L4-L6—S(O)m—N(R5)—L5—, (f) —L4—N(R5)—C(W)—L7-L5—, (g) —L4—N(R5)—S(O)p—L7—L5—, (h) optionally substituted alkylene, (i) optionally substituted alkenylene, and (j) optionally substituted alkynylene are inhibitors of protein isoprenyl transferases. Also disclosed are protein isoprenyl transferase inhibiting compositions and a method of inhibiting protein isoprenyl transferases.